A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 41/00 (2006.01) A61K 49/00 (2006.01) A61K 49/22 (2006.01)
Patent
CA 2335808
Texaphyrins are selectively retained in diseased tissue cells. When exposed to low level, non-thermal sonodynamic agent such as ultrasound, the texaphyrin- incorporated cells are selectively destroyed. There is provided a method of sonodynamic therapy by administering an effective amount of an intracellular sensitizer to a mammal in need thereof and providing an effective amount of a sonodynamic agent.
Des texaphyrines sont retenues sélectivement dans des cellules de tissus malades. Lorsqu'elles sont exposées à un agent sonodynamique non-thermique, à faible niveau, par exemple, des ultrasons, les cellules renfermant de la texaphyrine sont détruites sélectivement. L'invention concerne un procédé de traitement sonodynamique consistant à administrer une quantité efficace d'un sensibiliseur intracellulaire à un mammifère en demande et à fournir une quantité efficace d'un agent sonodynamique.
Kessel David
Woodburn Kathryn W.
Bereskin & Parr
Pharmacyclics Inc.
LandOfFree
Intracellular sensitizers for sonodynamic therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular sensitizers for sonodynamic therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular sensitizers for sonodynamic therapy will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1952584